Bigul

SICAGEN INDIA LTD. - 533014 - Proposal For Voluntary Delisting Of Equity Shares From National Stock Exchange

The Board of Directors of the Company has, at its meeting held today, considered and approved the proposal for voluntary delisting of equity shares from the National Stock Exchange of India Ltd ('NSE') as per Regulation 6(a) and 7 of SEBI (Delisting of Equity Shares) Regulations, 2009. The Equity Shares of the Company will continue to be listed on the Bombay Stock Exchange Limited ("BSE"), which has nationwide trading terminals. Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the decision taken by the Board on the above subject matter is submitted to the Stock Exchanges. The above meeting was held through Video Conference and commenced at 9.00 a.m. and concluded at 9.56 a.m.
23-04-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Sicagen India Ltd has submitted to BSE a copy of Clarification is enclosed.
20-04-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Considering The Proposal For Voluntary Delisting Of Shares Through Video Conference.

SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2020 ,inter alia, to consider and approve voluntary delisting of equity shares from National Stock Exchange (NSE).
20-04-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Clarification sought from Sicagen India Ltd

The Exchange has sought clarification from Sicagen India Ltd on April 13th, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
13-04-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Cancellation of Board Meeting

The Board Meeting to be held on 31/03/2020 Stands Cancelled.
25-03-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Considering Voluntary Delisting Of Equity Shares From National Stock Exchange Of India Ltd (NSE)

SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/03/2020 ,inter alia, to consider and approve the proposal for voluntary delisting of equity shares of the Company from National Stock Exchange of India Ltd (NSE) as per Regulation 6(a) & 7 of the SEBI (Delisting of Equity Shares)Regulation, 2009. The equity shares of the Company will remain to be listed on Bombay stock Exchange Ltd (BSE), which has nationwide terminals.
20-03-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Appointment Of Chief Financial Officer Of The Company

The Board of Directors of the Company at their meeting held today appointed Mr.M.O.Ayyappan as Chief Financial Officer (CFO) of the Company with effect from 07.02.2020 as recommended by Nomination and Remuneration Committee. Mr.M.O.Ayyappan, aged about 52 years, is a M.Com and MBA (Finance) graduate and having over 27 years of vast experience in corporate finance and accounts functions. He has worked in various capacities in the organization.
07-02-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2019

The Board of Directors of the Company at its meeting held today, has inter alia considered and approved the Unaudited Financial Results (standalone and consolidated Results) of the Company for the quarter and nine months ended 31st December 2019. Copies of the aforesaid results together with Limited review report of the statutory auditors are attached.
07-02-2020
Bigul

Sicagen India Ltd - 533014 - Board Meeting Intimation for Consideration Of Unaudited Financial Results Of The Company For The Quarter Ended 31St December 2019.

SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter ended 31st December 2019.
24-01-2020
Bigul

SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- G ArunmozhiDesignation :- Company Secretary and Compliance Officer
21-01-2020
Next Page
Close

Let's Open Free Demat Account